• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: Penpulimab
Date Designated: 02/23/2021
Orphan Designation: Treatment of nasopharyngeal carcinoma
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Akeso Biopharma, Inc.
6 Shennong Road, Torch Development Zone
Zhongshan, Guangdong 528437

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.